GIP peptides suffer from extremely short half-lives due to enzymatic breakdown. Preventing this instability is essential for maintaining therapeutic efficacy in metabolic regulation.

Excessive adipose tissue accumulation in small-breed dogs with dietary sensitivities. Addressing this prevents obesity-related comorbidities and chronic inflammation in pets with restricted dietary profiles.

Pathogenic viral infection and cognitive decline in aging canines. Mitigating these failures improves survival rates and functional longevity.